EE374 Budget Impact of Adalimumab Sandoz (BIOSIMILAR) in Comparison to Adalimumab- Reference Product in the Management of Autoimmune Diseases in Dubai

Autoimmune disorders (AD) such as Rheumatoid Arthritis, Ankylosing Spondyloarthropathy, Ulcerative Colitis, Crohn ’s disease, Psoriatic Arthritis, Uveitis and Hidradenitis suppurativa have partially overlapping clinical manifestations of inflammation. Adalimumab Sandoz (biosimilar) is commonly used for management of several ADs.

Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: M Farghaly, MA Sara Ahmad, Y Sharma, SS Sultana, O Mohammed Source Type: research